Source: TH
Context: The rise in fatty liver disease, now termed Metabolic dysfunction-associated steatotic liver disease (MASLD), is closely linked to metabolic syndrome, including obesity, diabetes, high blood pressure, and abnormal cholesterol levels.
- MASLD, particularly its progressive form known as Metabolic dysfunction-associated steatohepatitis (MASH), which causes liver inflammation and scarring, is expected to become the leading cause of chronic liver disease and liver transplants.
- Global MASLD prevalence is around 25-30%, with India’s adult prevalence at 38.6% and 36% among obese children.
